Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

US Patent 10561669 · Granted Feb 18, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral topiramate suspension formulations with extended shelf stability and enhanc2025
Methotrexate composition2025
Methotrexate composition2025
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Oral quetiapine suspension formulations with extended shelf life and enhanced bi2024
Methotrexate composition2024
Methotrexate composition2024